Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.A-Bio Pharma, a biologics contract manufacturer, has appointed Steven Lee, as its new CEO.
Subscribe to our email newsletter
Dr Lee joins A-Bio from Bristol Myers Squibb Company, where he held the position of vice president and general manager of the Syracuse, New York manufacturing and process development complex overseeing over 800 employees and a wide range of biological drugs and development candidates including antibody therapeutics.
Prior to joining BMS in 2002, Dr Lee was director of fermentation and cell culture development at Merck’s West Point, Pennsylvania vaccine facility, where he held several positions of increasing responsibility at Merck Research Laboratories and Merck Manufacturing Division since joining in 1990.
Dr Lee received his doctorate in biochemical engineering from the Massachusetts Institute of Technology and a master’s in chemical engineering from the University of Michigan, Ann Arbor.
Chu Swee Yeok, CEO of Bio One Capital, said: “I am very pleased that Steve has taken the helm at A-Bio. Steve has many years of biologics manufacturing experience. He will bring his invaluable seasoned perspective to A-Bio and lead the company into the next important phase of expansion and exciting growth.”